Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) EPS (Weighted Average and Diluted) (2018 - 2024)

Skinvisible's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $0.08 for Q4 2024.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 233.33% to $0.08 in Q4 2024 year-over-year; TTM through Dec 2024 was -$0.11, a 78.43% increase, with the full-year FY2024 number at -$0.11, up 78.85% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.08 in Q4 2024 for Skinvisible, up from -$0.06 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for SKVI hit a ceiling of $0.08 in Q4 2024 and a floor of -$0.33 in Q1 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.07 across 5 years, with a median of -$0.06 in 2021.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 560.0% in 2023 and later surged 233.33% in 2024.
  • Tracing SKVI's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.07 in 2020, then skyrocketed by 39.08% to -$0.04 in 2021, then tumbled by 125.0% to -$0.09 in 2022, then surged by 33.33% to -$0.06 in 2023, then surged by 233.33% to $0.08 in 2024.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SKVI at $0.08 in Q4 2024, -$0.06 in Q3 2024, and -$0.07 in Q2 2024.